Related Experiment Video
Updated: Jul 10, 2026
14:26
A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
Sleep in peri-menopausal and post-menopausal women
A D Krystal1, J Edinger, W Wohlgemuth
1The Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27710, USA. krystal@cs.duke.edu
Sleep Medicine Reviews
|August 18, 2004
Summary
Menopausal women often experience insomnia due to hormonal changes causing night sweats and arousals. Persistent insomnia may stem from behavioral conditioning or other sleep disorders, requiring proper diagnosis and treatment.
Area of Science:
- Reproductive Endocrinology
- Sleep Medicine
- Women's Health
Background:
- Sleep disturbances are commonly reported by women during peri-menopause and post-menopause.
- There is a significant gap in scientific literature regarding sleep disorders specific to these menopausal stages.
- Existing research suggests a potential link between menopausal changes and insomnia.
Purpose of the Study:
- To review the available literature on sleep disturbances in peri-menopausal and post-menopausal women.
- To explore the relationship between menopausal hormonal changes and insomnia.
- To provide diagnostic and treatment guidelines for menopausal women with sleep complaints.
Main Methods:
- Comprehensive literature review of studies on menopause and sleep.
- Analysis of hormonal influences on sleep patterns during menopausal transition.
- Examination of potential contributing factors to persistent insomnia.
Main Results:
- Hormonal fluctuations during peri/post-menopause, particularly night sweats, can lead to increased sleep arousals and insomnia.
- Insomnia may persist after hormone replacement therapy due to behavioral conditioning or co-existing sleep disorders.
- Menopausal changes may indirectly increase the risk for conditions like sleep apnea.
Conclusions:
- Insomnia is frequently associated with menopausal transition, often triggered by hormonal changes and night sweats.
- Persistent insomnia may require evaluation for behavioral conditioning or independent sleep disorders.
- Guidelines are proposed for the diagnosis and management of sleep complaints in peri/post-menopausal women.
Related Concept Videos
01:24Sleep-Wake Cycles
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:11Understanding Sleep
Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...